Airway diseases
Respiratory infections
State of the art session
Airway diseases
Clinical
Is there a problem with...? Treatment approaches in asthma and COPD
Aims : To evaluate the use of short-acting beta-2 agonist (SABA) monotherapy and oral corticosteroid (OCS) use in asthma; to describe concerns related to the use of inhaled corticosteroids (ICS) in COPD; and to determine the optimal inhalation device for patients with COPD.
Target audience :
Adult pulmonologist/Clinician, Clinical researcher, General practitioner, Medical Student, Patient, Respiratory physiotherapist, Nurse, Respiratory critical care physician
11:50
Introduction
1
4511
11:55
Is there a problem with short-acting beta-2 agonist monotherapy in asthma?
D. Price(Singapore, Singapore)
COI
-
Description
2
4512
12:05
Is there a problem with oral corticosteroid use in asthma?
G. Brusselle(Ghent, Belgium)
COI
-
Description
3
4513
12:15
Is there a problem with inhaled corticosteroid use in COPD?
J. Chalmers(Dundee (Angus), United Kingdom)
COI
-
Description
4
4514
12:25
ERS Short Guideline: Inhaled corticosteroid withdrawal in COPD
M. Miravitlles(Barcelona (CT), Spain)
COI
5
4515
12:35
Discussion and Q&A
6
4516
. . .